Moleculin Biotech ( ($MBRX) ) has issued an announcement. On November 13, 2025, Moleculin Biotech announced that 60% of the target subjects have ...

GRAIL, Inc. reports Q3 revenue growth and promising cancer test data, but faces challenges in approval and profitability.

The data center industry is poised to push Oklahoma utilities to their demand limits. Regulators emphasize careful cost ...

Anixa Biosciences to present a more complete phase 1 data readout at SABCS in December. Read my ANIX stock update and know ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

And not every firm with a spotless payment history is thrilled to be handed a rating at the low end of junk (although there ...

Identity resolution often anchors vendor pitches. Vendors claim CDPs can merge disparate identifiers into coherent customer records. But the reality is more complicated. Email addresses change, ...

The "OK Boomer" phenomenon reflects deep generational divides in American politics, with younger voters increasingly ...

New research reveals that men need twice as much exercise as women to prevent heart disease. The study shows that women ...

On-chain analysts can’t stop a crash, but by tracking capital movement, leverage, and sentiment, they can spot the storm before it hits. Metrics like MVRV-Z, ...